Expert blog

Aug. 15, 2017
  1. Wein AJ, et al., eds. Diagnosis and staging of prostate cancer. In: Campbell-Walsh Urology. 11th ed. Philadelphia, Pa.: Elsevier; 2016. Accessed Jan. 25, 2016.
  2. Dawson NA. Overview of the treatment of disseminated prostate cancer. Accessed Jan. 25, 2016.
  3. Niederhuber JE, et al., eds. Prostate cancer. In: Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. Accessed Jan. 26, 2016.
  4. Lee RJ, et al. Initial systemic therapy for castration sensitive prostate cancer. Accessed Jan. 25, 2016.
  5. Roach M. Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer. Cancer. 2014;120:1620.
  6. Smith MR, et al. Side effects of androgen deprivation therapy. Accessed Jan. 25, 2016.
  7. Dawson NA. Secondary endocrine therapies for castration resistant prostate cancer. Accessed Jan. 25, 2016.
  8. Steele GS, et al. Radical inguinal orchiectomy for testicular germ cell cancers. Accessed Jan. 25, 2016.

Hormone therapy for prostate cancer